You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 17, 2025

List of Excipients in API acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg

Detailed excipient profiles for acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg

Excipient focus: CARNAUBA WAX

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing CARNAUBA WAX

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: CROSCARMELLOSE SODIUM

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing CROSCARMELLOSE SODIUM

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: FERROSOFERRIC OXIDE

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing FERROSOFERRIC OXIDE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: GLYCERYL DIBEHENATE

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing GLYCERYL DIBEHENATE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: HYPROMELLOSE

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing HYPROMELLOSE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: POLYDEXTROSE

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing POLYDEXTROSE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: POLYETHYLENE GLYCOL

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing POLYETHYLENE GLYCOL

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: PROPYLENE GLYCOL

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing PROPYLENE GLYCOL

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: SILICON DIOXIDE

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing SILICON DIOXIDE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: SODIUM LAURYL SULFATE

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing SODIUM LAURYL SULFATE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: STARCH, CORN

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing STARCH, CORN

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: TITANIUM DIOXIDE

acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg drug variants not containing TITANIUM DIOXIDE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group